Jose Estabil

Chief Business Officer at Cipherome, Inc

Jose Estabil has an extensive work experience spanning over several companies and roles. Jose is currently the Chief Business Officer at Cipherome, Inc, where they focus on personalized drug treatment to reduce preventable drug reactions. In addition, they are a Founding Venture Partner at AccelHub Venture Partners, working towards developing a community of investors for startups ready to scale in the US.

Before their current roles, Jose worked at the Massachusetts Institute of Technology as the Director of Entrepreneurship and Innovation, leading various programs. Prior to that, they served as the President of tau-Metrix, Inc and as the Senior Director of Technology at KLA-Tencor.

Jose also had significant experience at Schlumberger, where they held various positions including Japan Manager, VP of Marketing for non-oilfield businesses, and was responsible for creating and launching the company's semiconductor sales, marketing, and customer group in Japan.

Earlier in their career, Jose worked at KLA-Tencor as the Director of Product Management, where they led cross-functional projects and received industry product honors for establishing dominant technology in a fast-paced Silicon Valley environment.

Throughout their career, Jose has demonstrated expertise in business development, entrepreneurship, innovation, and marketing.

Jose Estabil attended Brown University, where they obtained a Sc. B. degree in Physics. Jose further pursued their education at Brown University and received a Sc. M. degree in Physics. However, specific start and end years for these degrees were not provided.

Location

Boston, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Cipherome, Inc

Cipherome is a biotech company that finds the drug that works for each individual. Its company was founded on the belief that each individual deserves the best medicine. Serious side effects or adverse drug reactions (ADRs) occur in certain individuals, but not in others. These differences may be due to inherited factors. Its unique patentedplatform combines many components, including genetics, to provide the best drug for everyone.


Employees

11-50

Links